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Abstract: We sought to determine if there was an intergenerational association between parental
weight, cardiorespiratory fitness (CRF), and disease status, with the prevalence of metabolic syndrome
(MetSyn) in their young adult offspring. Young adults (n = 270, 21 ± 1 years, 53.3% female) were
assessed for MetSyn and self-reported parent’s CRF, body mass status, and disease status. MetSyn was
present in 11.9% of participants, 27.4% had one or two components, and 58.5% had no components.
A significantly higher percentage (93.9%) of young adults with MetSyn identified at least one parent
as being overweight or obese, 84.8% reported low parental CRF and 87.9% reported a parent with
disease (all p < 0.017). MetSyn in offspring is more likely when parents are perceived to have low CRF,
increased body mass, and a diagnosis of disease. Evaluating the offspring of people with low CRF,
elevated body mass, or who have a history of cardiovascular disease (CVD) or diabetes should be
considered to promote early identification and treatment of young adults to reduce future premature
CVD in these at-risk individuals.
Keywords: metabolic syndrome; young adult; primordial prevention; primary prevention;
cardiovascular disease screening
1. Introduction
Metabolic Syndrome (MetSyn) encompasses a broad range of metabolic abnormalities [1], which
is reported to be present in 20–30% of adults worldwide [2]. MetSyn prevalence varies with age and is
present in 5–7% of apparently healthy young adults worldwide [3]. There is a two-fold increase in the
risk of developing cardiovascular disease (CVD) and a five-fold increase in the risk of developing type
2 diabetes mellitus in people with MetSyn [4]. Early identification of the presence of MetSyn allows
for a greater opportunity of reversal and prevention of subsequent clinical disease, highlighting the
clinical importance of early identification of MetSyn to reduce lifetime disease risk.
Lifestyle interventions focusing on increasing physical activity levels, improving diet, and weight
loss are effective in reducing MetSyn in young adults [5,6]. However, the identification of young adults
who have a higher risk of MetSyn and, therefore, the development of clinical disease is difficult. For
example, despite cholesterol screening being recommended for adults from the age of 20 years [6],
less than 50% of 20–35-year-old males and 20–45-year-old females participate in cholesterol screening.
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Furthermore, rates of cholesterol screening appear to be no different in young adults with differing
levels of CVD risk factors [7]. Thus, there appears to be a clear need for new approaches to identify
young adults with a high lifetime CVD risk in order to prevent future CVD.
There is clear evidence of intergenerational links for CVD and CVD risk factors between parents
and offspring [8–10]. Moreover, one of the traditional CVD risk factors is having a father with
diagnosed CVD under the age of 55 years or having a mother with diagnosed CVD under the age of 65
years [11]. Despite this knowledge, studies that have specifically looked at the association between
MetSyn in the offspring of people with a diagnosis of CVD or diabetes are rare. Furthermore, there is
sparse information on the association between parent’s lifestyle and their offspring’s MetSyn status.
Therefore, the aim of this preliminary study was to determine the association between perceived parent
cardiorespiratory fitness (CRF), body mass, and disease status, and the presence of MetSyn in young
adults. We hypothesised that parents of young adults with MetS are more likely to have low CRF, be
overweight or obese, and have either CVD or diabetes.
2. Materials and Methods
Young adult (18–25 years) participants (n = 270, 53.3% female) were recruited from Colorado,
the United States of America (n = 139), and Auckland, New Zealand (n = 131). Participant
recruitment was performed using a combination of poster advertisement and in-lecture presentation to
large undergraduate classes at the University of Auckland and Western State Colorado University.
Participants that had known underlying metabolic conditions, such as polycystic ovary syndrome,
type 2 diabetes mellitus, or were pregnant or lactating at the time of assessment, were excluded from
this study. Participants attended the testing laboratory after an overnight fast, avoidance of vigorous
physical activity in the preceding 24 h, and abstinence from caffeine or tobacco in the preceding four
hours. After obtaining informed consent, participants were asked to answer closed yes or no questions
regarding their perception of their parent’s CRF, body mass, CVD, and diabetes status (see Table 1).
Participants were instructed to answer yes, if either of their parents were obese, if either of their parents
were overweight, and instructed to answer yes if either parent, in their opinion, had good CRF.
Table 1. Questions asked about parental cardiorespiratory fitness, body mass status, and diabetes and
cardiovascular disease status.
Question
Do you consider your parents to be obese?
Do you consider your parents to be overweight?
Do you consider your parents to have good cardiorespiratory fitness?
Do either of your parents have diabetes?
Do either of your parents have heart disease (heart attack, stent, angina, bypass etc.)?
Subsequent to the informed consent process and questionnaire (approximately 10 min of seated
rest), resting blood pressure (BP) and heart rate (HR) were recorded with the participant’s feet on the
floor and arm supported at heart level with an automated sphygmomanometer (Life Brand, Toronto,
ON, Canada; Omron HEM-705CP, Bannockburn, IL, USA).
2.1. Total Body Mass, Height and Waist Circumstance
Participant’s height and total body mass were recorded to the nearest 0.1 kg and 0.1 cm in duplicate
using calibrated digital scales (SECA770, Germany) and a standard stadiometer (SECA217, Germany).
Waist circumference (WC) was measured in the standing position at the narrowest point between
the iliac crest and the 11th and 12th ribs using either a metal tape (Lufkin W606PM, Apex tool group
LLC, Sparks, MD, USA) or cloth tape with spring loaded handle (Creative Health Products, Ann Arbor,
MI, USA).
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BP, HR, total body mass, height, and WC were measured in duplicate with the mean of the two
measures recorded as the final datum point. When two measures were outside the acceptable range (BP
± 5 mmHg, HR ± 5 bpm, WC ± 1.0 cm, mass ± 0.1 kg, height ± 1 cm), a third measure was performed
and the median of the three measurements was recorded as the final datum point.
2.2. Blood Measures
Blood lipid and glucose measures were analysed via a Cholestech LDX System (Alere Inc.,
Waltham, MA, USA). A finger prick was made on the participant’s ring finger of their non-dominant
hand using aseptic techniques. Blood was sampled using a small capillary tube that was inserted
into a preloaded cassette for immediate analysis. Triglyceride (TG) level, high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol, and fasting blood
glucose (FBG) were directly measured or estimated using the Friedewald formula. When blood lipids
were outside the detectable upper or lower limit of the Cholestech LDX System (n = 33), the last
detectable value for that variable was substituted. This procedure does not affect the ability to detect
MetSyn components.
2.3. Participant Classification
MetSyn component data (BP, HDL-C, TG, FBG, and WC) collected from participants were evaluated
against harmonised MetSyn criteria [4]. Participants were stratified as healthy if no components were
present, at-risk if one or two components were present, and present if three or more components
were present.
2.4. Statistical Analysis
A one-way ANOVA, adjusted for sex and site of assessment, was performed to determine
differences in participant characteristics across the three groups (present, at-risk, and healthy). To
determine specific group differences, post-hoc pairwise analysis utilizing a Bonferroni correction for
multiple comparisons were performed if statistically significant results were present.
To determine the association between parent’s CRF, parent’s body mass, and parent’s chronic
disease status, a series of chi-square analyses was performed. When significant results were present,
post-hoc z-column proportion analysis utilizing a Bonferroni correction for multiple comparisons was
performed to determine specific group differences.
Statistical significance was set at p < 0.05 for the one-way ANOVA and chi-square analysis. Where
multiple comparison occurred in post-hoc testing, a Bonferroni correction was applied. Therefore,
statistical significance was set at p < 0.017 for post-hoc testing of all analyses involving the healthy,
at-risk, and present groups.
All analyses were performed using IBM SPSS statistics version 25 (IBM Corporation, New York,
NY, USA).
All study protocols were approved by the relevant local ethics and institutional review boards
(Auckland 012544, Colorado HRC2013-0261R3).
3. Results
One hundred and fifty eight participants (58.5%) had no MetSyn components (healthy), 74
participants (27.4%) had one or two components (at-risk), and 32 participants (11.9%) had three or
more components (present).
There was no between age group differences, and no differences in resting HR or estimated CRF
between the at-risk and healthy groups. There was no significant difference in HDL-C in the present
and at-risk groups. All other comparisons were statistically significant between groups (see Table 2).
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Table 2. Participant characteristics categorised by metabolic syndrome group.
Parameter Healthy (n = 158) At-Risk (n = 74) Present (n = 32)
Age (years) 21 ± 1 21 ± 1 21 ± 1
Resting HR (bpm) 63 ± 9 66 ± 10 75 ± 6 b,c
Resting SBP (mmHg) 114 ± 8 124 ± 11 a 135 ± 6 b,c
Resting DBP (mmHg) 70 ± 7 77 ± 9 a 84 ± 5 b,c
BMI (kg·m−2) 22.0 ± 2.9 24.4 ± 3.7 a 30.3 ± 3.8 b,c
WC (cm) 76.2 ± 8.3 80.0 ± 8.9 a 97.8 ± 6.3 b,c
TG (mmol·L−1) 0.90 ± 0.35 1.10 ± 0.53 a 2.33 ± 0.68 b,c
HDL-C (mmol·L−1) 1.60 ± 0.33 1.13 ± 0.35 a 1.02 ± 0.13 b
FBG (mmol·L−1) 4.70 ± 0.35 4.93 ± 0.44 a 5.69 ± 0.30 b,c
All data displayed as mean ± S.D.; a statistically significant difference (p ≤ 0.0017) between healthy and at-risk; b
statistically significant difference (p ≤ 0.0017) between healthy and present groups; c statistically significant difference
(p ≤ 0.0017) between at-risk and present groups. Healthy—no metabolic syndrome components; at-risk—one or
two metabolic syndrome components; present—three or more metabolic syndrome components; HR—heart rate;
SBP—systolic blood pressure; DBP—diastolic blood pressure; BMI—body mass index; WC—waist circumference;
TG—triglyceride; HDL-C—high-density lipoprotein cholesterol; FBG—fasting blood glucose.
Association between Parent’s Status and Metabolic Syndrome Status
Table 3 displays the percentage of participants within each MetSyn group that had a parent with
each characteristic. Many participants (n = 158) indicated at least one parent was overweight or obese.
There was a significantly greater prevalence of parents with at least one parent who were overweight
or obese in the present group (93.9%, p ≤ 0.0017). Furthermore, in the present group a similar result
was seen in regards to parental CRF (15.2%, p ≤ 0.0017), and disease status (87.9%, p ≤ 0.0017).
Table 3. Prevalence of participants in each metabolic syndrome group with a parent with or without
poor cardiorespiratory fitness, increased body mass, or cardiometabolic disease.
Parameter Healthy (n) At-Risk (n) Present (n)
Parent’s mass status
≥1 overweight or obese 50.3% (81) 60.5% (46) 93.9% (31) a,b
No overweight or obese 49.7% (80) 39.5% (30) 6.1% (2) a,b
Parent’s cardiorespiratory fitness status
≥1 good CRF 70.8% (114) 55.3% (42) 15.2% (5) a,b
Both parents poor CRF 29.2% (47) 44.7% (34) 84.8% (28) a,b
Parent’s disease status
≥1 CVD or diabetes 27.3% (44) 30.3% (23) 87.9% (29) a,b
No CVD or diabetes 72.7% (117) 69.7% (53) 12.1% (4) a,b
a statistically significant difference (p ≤ 0.0017) between healthy and present groups. b statistically significant
difference (p ≤ 0.0017) between at-risk and present groups. Healthy—no metabolic syndrome components;
at-risk—one or two metabolic syndrome components; present—three or more metabolic syndrome components;
CVD—cardiovascular disease; ≥1—one or both.
The majority of young adults with MetSyn had a parent who had disease, was overweight, and
was “unfit” (84.8% of present group). Conversely, the highest percentage of healthy participants
reported parents did not have disease, were not overweight or obese, and one or more had good fitness
(31.7%) (see Table 4).
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Table 4. Association between all three parental characteristics and metabolic syndrome status.
Parental Status Offspring Status
Disease Mass CRF Healthy (%) At-Risk (%) Present (%)
≥1 CVD or Diabetes
No overweight or obese ≥1 fit 8.7 2.6 0.0
No fit 0.6 0 0.0
≥1 overweight or obese ≥1 fit 8.1 5.3 3.0
No fit 9.9 22.4 84.8
No CVD or diabetes
No overweight or obese ≥1 fit 31.7 26.3 6.1
No fit 8.7 10.5 0.0
≥1 overweight or obese ≥1 fit 22.4 21.1 6.1
No fit 9.9 11.8 0.0
Healthy—no metabolic syndrome components; at-risk—one or two metabolic syndrome components; present—three
or more metabolic syndrome components; CVD—cardiovascular disease; CRF—cardiorespiratory fitness; ≥1—one
or both.
4. Discussion
The main finding of this preliminary study is that there is an association between parental CRF,
body mass status, chronic disease status, and young adult offspring’s MetSyn status. The current study
strongly suggests that young adults with at least one parent who has low CRF, is overweight or obese,
or has CVD or diabetes, may already have a detectable increase in their lifetime risk for CVD and
diabetes. Fortunately, early intervention in the young adult offspring of people with low CRF, increased
body mass, and CVD or diabetes may help curb development of MetSyn and the associated risk for
future development of CVD and diabetes. Therefore, consideration of targeted cardiometabolic health
screening in young adults who have parents with the characteristics described, may be warranted to
break the cycle of intergenerational cardiometabolic disease.
Several large cohort epidemiological studies have shown a familial aggregation of CVD risk
factors [8,9,12] with parental-offspring correlations being stronger than spousal correlations suggestive
of a strong genetic component [12]. Moreover, there are reports of MetSyn aggregation between
generations [13] with both genetic and environmental factors being influential [14]. The current
findings support these previous reports and suggest that MetSyn is higher in young adults who
self-report having a parent with CVD or diabetes than their peers who do not. Importantly, we provide
preliminary evidence of a link between parental CVD and diabetes and an early pre-clinical syndrome
(i.e., MetSyn). Therefore, to reduce future CVD rates, one public health strategy could be to assess
offspring of people with new diagnoses of CVD or diabetes for CVD risk with the intention of providing
primary or primordial prevention services.
In addition to established parental disease, the current findings also suggest that young adults
who report a parent with low CRF or are overweight or obese have increased prevalence of MetSyn.
The role of lifestyle in the development of CVD [15] is well established, so this finding is not unexpected.
However, the association with parental lifestyle and their offspring’s MetSyn status is not clearly
elucidated. Speculatively, in the current study many of the participants still resided with their parents
and, therefore, the influence of parent’s lifestyle may have influenced the participant’s current lifestyle,
therefore MetSyn status.
There are significant reductions in MetSyn with increases in CRF with exercise training [16,17],
the association of parental fitness with MetSyn in their offspring is less well known. In the current
study, there was a much lower prevalence of MetSyn in participants who reported having at least
one parent with good CRF when considering participants who reported at least one parent who had
increased body mass and had CVD or diabetes (3.0% good CRF parent vs. 84.8% poor CRF parent).
While, we know unfortunately that due to the self-report methodology in the current study, we cannot
rule out the possibility that participants were unable to discern the difference between CRF and fatness
or may have perceived a parent with disease as automatically having poor CRF. However, given there
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is such a large difference in the percentage of young adults based on parent’s CRF status, future studies
may wish to address this intriguing result.
Limitations
The current study used a self-report questionnaire and parent’s CRF and body mass were not
directly measured, and parents were not directly asked about their diagnosis of CVD or diabetes.
Therefore, there may be some recall error on behalf of the participant and some parents may have been
incorrectly classified. Furthermore, we did not collect information on the parent’s ages. However,
despite these limitations in data collection about parents, we were still able to detect significant
differences in the prevalence of MetSyn in participants. Furthermore, our results largely agree with
previous research on intergenerational CVD risk factors. Therefore, we are confident that the results
presented in this preliminary study would be replicated with a more robust, direct measurement of
CRF, body mass, and disease status in young adult’s parents.
We did not collect information on which parent had poor CRF, increased body mass, CVD or
diabetes. Furthermore, we categorised obese and overweight parents together and there may be
different relationships in offspring health depending on the degree of parental mass. Collectively,
further classification and direct measurement of parental characteristics may have helped strengthen
associations. For example, there is evidence to suggest a stronger maternal effect on MetSyn components
than paternal in adolescents [18], although this is not a consistent finding [9]. Further investigations
should focus on these differences to establish the effect of maternal or paternal health on offspring
cardiometabolic health.
5. Conclusions
We have provided preliminary evidence that parents perceived to have low CRF, increased body
mass, and a diagnosis of CVD or diabetes are associated with offspring more likely to have MetSyn.
While, larger studies with direct measurements of both parental and offspring mass, CRF, and disease
status are required to confirm these preliminary findings, consideration should be given to evaluating
the offspring of people with low CRF, increased body mass, or newly diagnosed CVD or diabetes
patients, in order to reduce future premature CVD in these at-risk individuals. Providing early lifestyle
intervention to reverse or modify known risk factors for chronic disease in young adults whom have a
parent with CVD or diabetes may help to break the intergenerational cycle of CVD and diabetes.
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